← ORTHOPEDIATRICS CORP KIDS
Market Price
$24.84
Market Cap
$643.15M
P/E Ratio
N/A
Revenue (FY 2025)
↑15.4% YoY
$236.35M
3-Yr CAGR: 24.6%
Net Income
↓-4.8% YoY
-$39.65M
Net Margin: -16.8%
Free Cash Flow
↑61.4% YoY
-$15.96M
FCF Yield: -2.48%
EPS (Diluted)
↓-3.0% YoY
$-1.69
Basic: $-1.69
Return on Equity
Efficiency
-11.4%
ROA: -674.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (KIDS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $37.3M | — | $26.4M | $-6.6M | — | $-7.14 | — | $-1.1M | $-5.5M | — |
| FY 2017 | $45.6M | +22.3% | $34.5M | $-8.9M | -35.9% | $-5.86 | +17.9% | $-7.2M | $-12.4M | -127.3% |
| FY 2018 | $57.6M | +26.2% | $42.7M | $-12.0M | -34.6% | $-0.96 | +83.6% | $-15.6M | $-20.8M | -67.7% |
| FY 2019 | $72.6M | +26.0% | $54.6M | $-13.7M | -14.2% | $-0.94 | +2.1% | $-17.8M | $-29.6M | -42.0% |
| FY 2020 | $71.1M | -2.0% | $55.0M | $-32.9M | -139.9% | $-1.82 | -93.6% | $-18.5M | $-29.0M | +1.9% |
| FY 2021 | $98.0M | +37.9% | $73.4M | $-16.3M | +50.6% | $-0.84 | +53.8% | $-13.1M | $-21.2M | +27.1% |
| FY 2022 | $122.3M | +24.7% | $90.7M | $1.3M | +107.7% | $0.06 | +107.1% | $-21.8M | $-31.8M | -50.2% |
| FY 2023 | $148.7M | +21.6% | $111.3M | $-21.0M | -1,767.2% | $-0.92 | -1,633.3% | $-27.0M | $-43.9M | -38.1% |
| FY 2024 | $204.7M | +37.6% | $148.6M | $-37.8M | -80.3% | $-1.64 | -78.3% | $-27.0M | $-41.3M | +5.9% |
| FY 2025 | $236.3M | +15.4% | $172.7M | $-39.6M | -4.8% | $-1.69 | -3.0% | $-4.9M | $-16.0M | +61.4% |
Valuation
Market Price
$24.84
Market Cap
$643.15M
Enterprise Value
$725.28M
P/E Ratio
N/A
P/B Ratio
1.84
FCF Yield
-2.48%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
73.05%
Operating Margin
-16.60%
Net Margin
-16.78%
Return on Equity (ROE)
-11.44%
Return on Assets (ROA)
-674.74%
Asset Turnover
40.22x
Revenue 3-Yr CAGR
24.56%
Financial Health & Liquidity
Current Ratio
0.13
Cash Ratio
0.42
Debt / Equity
0.293
Debt / Assets
17.305
Cash & Equivalents
$19.56M
Total Debt
$101.68M
Book Value / Share
$13.49
Cash Flow Efficiency
Operating Cash Flow
-$4.85M
Capital Expenditures (CapEx)
$11.11M
Free Cash Flow
-$15.96M
OCF / Revenue
-2.05%
FCF / Revenue
-6.75%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-1.69
EPS (Basic)
$-1.69
Dividends / Share
N/A
Book Value / Share
$13.49
EPS YoY Growth
-3.05%
Balance Sheet (FY 2025)
Total Assets
$5.88M
Total Liabilities
$46.20M
Stockholders' Equity
$346.60M
Current Assets
$5.88M
Current Liabilities
$46.20M